BC
Bicara Therapeutics Inc. Common Stock (BCAX)
NASDAQ·Healthcare·Biotechnology
$21.69
+1.17%
Mkt Cap $1.19B
Analyst Ratings
Buy
4
Hold
3
Sell
0
Price Target (7 analysts)
$20.00
Range $14.00 – $28.00
Implied Upside
-7.8%
Consensus $20.00 vs current $21.69